Related Experiment Video
Updated: Jun 8, 2025

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Racism in Drug Testing
Jacqueline A Hubbard1, Kamisha L Johnson-Davis2
1Hubbard Lab Consulting, 6016 Hawthorn Drive, Coraopolis, PA 15275, USA.
Abstract:
Racial disparities in drug testing for substance-use disorders underscore systemic inequalities. Studies reveal that minority groups, particularly Black and Hispanic Americans, are disproportionately targeted for drug testing despite similar rates of drug use across racial lines. Such bias impacts employment opportunities, legal outcomes, and access to treatment. The overrepresentation of minorities in drug testing reflects broader societal prejudices, leading to a cycle of discrimination and marginalization. Addressing these disparities requires a multifaceted approach, including policy reform, increased awareness of implicit biases, and equitable health care practices to ensure fair treatment of all individuals struggling with substance-use disorders.
Related Concept Videos
Stereotypes, Prejudice, and Discrimination
Confirmation Biases
Drug Regulation
Drug Excretion: Miscellaneous Routes
Stereotype Threat and Self-fulfilling Prophecies
Surveys

